Polymorphisms in the interleukin-6 receptor gene are associated with bone mineral density and body mass index in Spanish postmenopausal women

European Journal of Endocrinology

Volumn 157, Issue 5, 2007, Pages 677-684

  Bustamante, M ^a,b,c   Nogues X ^d   Mellibovsky, L ^d   Agueda, L ^a,b,c   Jurado, S ^d   Caceres E ^d   Blanch, J ^d   Carreras, R ^d   Diez Perez A ^d   Grinberg, D ^a,b,c   Balcells, S ^a,b,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b IBUB   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ALANINE; ASPARTIC ACID; CYTOSINE; GENOMIC DNA; GUANINE; INTERLEUKIN 6 RECEPTOR; TYROSINE;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FEMUR NECK; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OBESITY; PHENOTYPE; POSTMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; SPAIN;

BODY MASS INDEX; BONE DENSITY; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-6; SPAIN; VARIATION (GENETICS);

EID: 36549064221     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0389     Document Type: Article

References (45)

1. Deng HW, Chen WM, Conway T, Zhou Y, Davies KM, Stegman MR, Deng H & Recker RR. Determination of bone mineral density of the hip and spine in human pedigrees by genetic and life-style factors. Genetic Epidemiology 2000 19 160-177.
2. Deng FY, Lei SF, Li MX, Jiang C, Dvornyk V & Deng HW. Genetic determination and correlation of body mass index and bone mineral density at the spine and hip in Chinese Han ethnicity. Osteoporosis International 2006 17 119-124.
3. Huang QY & Kung AW, Genetics of osteoporosis. Molecular Genetics and Metabolism 2006 88 295-306.
4. Snyder EE, Walts B, Perusse L, Chagnon YC, Weisnagel SJ, Rankinen T & Bouchard C. The human obesity gene map: the 2003 update. Obesity Research 2004 12 369-439.
5. Barroso I. Genetics of type 2 diabetes. Diabetic Medicine 2005 22 517-535.
6. Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S, Findlay DM, Martin TJ, Hirota H, Taga T, Kishimoto T & Suda T. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. Journal of Experimental Medicine 1995 182 1461-1468.
7. Franchimont N, Lambert C, Huynen P, Ribbens C, Relic B, Chariot A, Bours V, Piette J, Merville MP & Malaise M. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. Arthritis and Rheumatism 2005 52 84-93.
8. Kallen KJ. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochimica et Biophysic Acta 2002 1592 323-343.
9. Lust JA, Donovan KA, Kline MP, Greipp PR, Kyle RA & Maihle NJ. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 1992 4 96-100.
10. Mullberg J, Dittrich E, Graeve L, Gerhartz C, Yasukawa K, Taga T, Kishimoto T, Heinrich PC & Rose-John S. Differential shedding of the two subunits of the interleukin-6 receptor. FEBS Letters 1993 332 174-178.
11. Muller-Newen G, Kohne C, Keul R, Hemmann U, Muller-Esterl W. Wijdenes J, Brakenhoff JP, Hart MH & Heinrich PC. Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing. European Journal of Biochemistry 1996 236 837-842.
12. Althoff K, Reddy P, Voltz N, Rose-John S & Mullberg J. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins. European Journal of Biochemistry 2000 267 2624-2631.
13. Bellido T, O'Brien CA, Roberson PK & Manolagas SC. Transcriptional activation of the (WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. Journal of Biological Chemistry 1998 273 21137-21144.
14. Jilka RL, Weinstein RS, Bellido T, Parfitt AM & Manolagas SC. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. Journal of Bone and Mineral Research 1998 13 793-802.
15. Erices A, Conget P, Rojas C & Minguell JJ. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. Experimental Cell Research 2002 280 24-32.
16. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H & Manolagas SC. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992 257 88-91.
17. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K Taga T et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. PNAS 1993 90 11924-11928.
18. Palmqvist P, Persson E, Conaway HH & Lerner UH. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-κB ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvariae. Journal of Immunology 2002 169 3353-3362.
19. Vermes C, Jacobs JJ, Zhang J, Firneisz G, Roebuck KA & Glant TT. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. Journal of Biological Chemistry 2002 277 16879-16887.
20. Abrahamsen B, Bonnevie-Nielsen V, Ebbesen EN, Gram J & Beck-Nielsen H. Cytokines and bone loss in a 5-year longitudinal study - hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study. Journal of Bone and Mineral Research 2000 15 1545-1554.
21. Giuliani N, Sansoni P, Girasole G, Vescovini R, Passeri G, Passeri M & Pedrazzoni M. Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Experimental Gerontology 2001 36 547-557.
22. Scheidt-Nave C, Bismar H, Leidig-Bruckner G, Woitge H, Seibel MJ, Ziegler R & Pfeilschifter J. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. Journal of Clinical Endocrinology and Metabolism 2001 86 2032-2042.
23. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S & Coppack SW Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. Journal of Clinical Endocrinology and Metabolism 1997 82 4196-4200.
24. Fried SK, Bunkin DA & Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. Journal of Clinical Endocrinology and Metabolism 1998 83 847-850.
25. Kado S, Nagase T & Nagata N. Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus. Acta Diabetologia 1999 36 67-72.
26. Vgontzas AN, Bixler EO, Papanicolaou DA & Chrousos GP. Chronic systemic inflammation in overweight and obese adults. Journal of the American Medical Association 2000 283 2235 (author reply 2236).
27. Jansson JO, Wallenius K, Wernstedt I, Ohlsson C, Dickson SL & Wallenius V. On the site and mechanism of action of the anti-obesity effects of interleukin-6. Growth Hormone and IGF Research 2003 13 (Suppl A) S28-S32.
28. Escobar-Morreale HF, Calvo RM, Villuendas G, Sancho J & San Millan JL. Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obesity Research 2003 11 987-996.
29. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA & Costantini E Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO Journal 1994 13 1189-1196.
30. Wolford JK, Colligan PB, Gruber JD & Bogardus C. Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians. Molecular Genetics and Metabolism 2003 80 338-343.
31. Hamid YH, Urhammer SA, Jensen DP, Glumer C, Borch-Johnsen K, Jorgensen T, Hansen T & Pedersen O. Variation in the interleukin-6 receptor gene associates with type 2 diabetes in Danish whites. Diabetes 2004 53 3342-3345.
32. Wang H, Zhang Z, Chu W, Hale T, Cooper JJ & Elbein SC. Molecular screening and association analyses of the interleukin 6 receptor gene variants with type 2 diabetes, diabetic nephropathy, and insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 2005 90 1123-1129.
33. Esteve E, Villuendas G, Mallolas J, Vendrell J, Lopez-Bermejo A, Rodriguez M, Recasens M, Ricart W, San Millan JL, Escobar-Morreale H, Richart C & Fernandez-Real JM. Polymorphisms in the interteukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome. Clinical Endocrinology 2006 65 88-91.
34. Galicia JC, Tai H, Komatsu Y, Shimada Y, Ikezawa I & Yoshie H. Interleukin-6 receptor gene polymorphisms and periodontitis in a non-smoking Japanese population. Journal of Clinical Periodontology 2006 33 704-709.
35. Barrett JC, Fry B, Maller J & Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 21 263-265.
36. Schaid DJ, Rowland CM, Tines DE, Jacobson RM & Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. American Journal of Human Genetics 2002 70 425-434.
37. Gauderman W & Morrison J. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies.
38. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M & Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005 21 2933-2942.
39. Prestridge DS. SIGNAL SCAN:, a computer program that scans DNA sequences for eukaryotic transcriptional elements. Computer Applications in the Biosciences 1991 7 203-206.
40. Mullberg J, Oberthur W, Lottspeich F, Mehl E, Dittrich E, Graeve L, Heinrich PC & Rose-John S. The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. Journal of Immunology 1994 152 4958-4968.
41. Huang QY, Shen H, Deng HY, Conway T, Davies KM, Li JL, Recker RR & Deng HW. Linkage and association of the CA repeat polymorphism of the IL6 gene, obesity-related phenotypes, and bone mineral density (BMD) in two independent Caucasian populations. Journal of Human Genetics 2003 48 430-437.
42. Xiong DH, Shen H, Zhao LJ, Xiao P, Yang TL, Guo Y, Wang W, Guo YE Liu YJ, Recker RR & Deng HW, Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction. Journal of Bone and Mineral Research 2006 21 1678-1695.
43. Zhao LJ, Guo YF, Xiong DH, Xiao P, Recker RR & Deng HW Is a gene important for bone resorption a candidate for obesity? An association and linkage study on the RANK (receptor activator of nuclear factor-κB) gene in a large Caucasian sample Human Genetics 2006 120 561-570.
44. Rosen CJ & Bouxsein MI. Mechanisms of disease: is osteoporosis the obesity of bone? Nature Clinical Practice. Rheumatology 2006 2 35-43.
45. Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR & Deng HW. Relationship of obesity with osteoporosis. Journal of Clinical Endocrinology and Metabolism 2007 92 1640-1646.